Chief Accounting Officer
Ginkgo Bioworks Holdings, Inc. (DNA)Equibles does not estimate personal net worth.
Get an email with a short summary when Ginkgo Bioworks Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get DNA alertsSteven P. Coen is recorded as Chief Accounting Officer at Ginkgo Bioworks Holdings, Inc. (DNA) since May 15, 2023 and CFO at Ginkgo Bioworks Holdings, Inc. (DNA). Ginkgo Bioworks Holdings, Inc. reported in an 8-K filed May 5, 2023 that Steven P. Coen was appointed Chief Accounting Officer, effective May 15, 2023. Steven P. Coen has spoken on 2 earnings calls across 1 company, most recently for Ginkgo Bioworks Holdings, Inc. on August 5, 2026. Ginkgo Bioworks Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ginkgo Bioworks Holdings, Inc. includes Jason Kelly (CEO and Board Member), Steven Coen (CFO), Reshma Shetty (COO and Board Member) and 7 others.
“In connection with Ms. Fallon's resignation and subject to the approval of the Company's Board of Directors, on May 5, 2023, the Company appointed Steven P. Coen, age 57, as its Chief Accounting Officer, effective May 15, 2023.”
“Before I walk through our financials, I want to remind everyone that following the previously announced transaction that closed on April 3rd, the divestiture of biosecurity is classified as discontinued operations within our financial status.”
“I'll start with the cell engineering business. Cell engineering revenue was $39 million in the second quarter of 2025, up 8% compared to the second quarter of 2024.”
2023-05-15–present
Biotechnology · Healthcare
CFO, Chief Accounting Officer
2023-05-15–present
